메뉴 건너뛰기




Volumn 5, Issue 4, 2008, Pages 331-334

Interview

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; EUROPEAN UNION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GOVERNMENT REGULATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MEDICOLEGAL ASPECT; PATENT; PHARMACOGENETICS; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIOECONOMICS;

EID: 50549089352     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.5.4.331     Document Type: Article
Times cited : (2)

References (4)
  • 1
    • 33750056914 scopus 로고    scopus 로고
    • Pharmacogenetics and pharmacogenomics: State-of-the-art and potential socio-economic impact in the EU
    • Zika E, Gurwitz D, Ibarreta D: Pharmacogenetics and pharmacogenomics: state-of-the-art and potential socio-economic impact in the EU. European Commission DG JRC/IPTS, EUR 22214 (2006) http://www.jrc.es/publications/ pub.cfm?prs=1387
    • (2006) European Commission DG JRC/IPTS, EUR , pp. 22214
    • Zika, E.1    Gurwitz, D.2    Ibarreta, D.3
  • 2
    • 50549097425 scopus 로고    scopus 로고
    • European Commission: Research Health http://ec.europa.eu/research/fp7/ index_en.cfm?pg=health
    • Research Health


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.